newsfilter
← Latest News
PR Newswire·

Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple myeloma

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat...